Controlled release from fibers of polyelectrolyte complexes.

Controlled release systems for delicate compounds, such as proteins, often suffer the drawbacks of decreased bioactivity and low encapsulation efficiency. This study introduces the concept of producing drug-loaded fibers from interfacial polyelectrolyte complexation. Chitosan-alginate fibers were produced by pulling from the interface between two polyelectrolyte solutions at room temperature. Depending on the component properties, the release time of encapsulated components from these fibers can range from hours to weeks. Dexamethasone was completely released within 2 h, whereas charged compounds such as BSA, PDGF-bb, and avidin showed sustained release for 3 weeks. The fibers were able to release PDGF-bb in a steady fashion for over 3 weeks without an initial burst. Furthermore, the bioactivity of PDGF-bb was retained over this period. Release kinetics could be controlled by the inclusion of heparin, which contains specific binding sites for various growth factors. By varying the alginate/heparin ratios in the anionic polyelectrolyte solution, the release of PDGF-bb could be significantly altered. In this study, interfacial polyelectrolyte complexation has been demonstrated to be a promising technique for producing drug-loaded fibers with high encapsulation efficiency, sustained release kinetics, and capacity to retain the bioactivity of the encapsulants.

[1]  Peter X Ma,et al.  The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. , 2004, Biomaterials.

[2]  A. Klibanov,et al.  Controling the rate of protein release from polyelectrolyte complexes. , 2003, Biotechnology and bioengineering.

[3]  K. Ohkawa,et al.  Preparation of Silk-Like Fibers Designed by Self-Assembled Ionic Polypeptides , 2003 .

[4]  Miqin Zhang,et al.  Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. , 2002, Journal of biomedical materials research.

[5]  E. Khor,et al.  Chitosan-alginate films prepared with chitosans of different molecular weights. , 2001, Journal of biomedical materials research.

[6]  Kam W. Leong,et al.  Mechanism of fiber formation by interfacial polyelectrolyte complexation , 2004 .

[7]  J. Sohier,et al.  A novel method to obtain protein release from porous polymer scaffolds: emulsion coating. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Hiroyuki Yamamoto,et al.  Polyion complex fiber and capsule formed by self-assembly of chitosan and gellan at solution interfaces , 2000 .

[9]  M. Brenner,et al.  Controlled release of nerve growth factor enhances sciatic nerve regeneration , 2003, Experimental Neurology.

[10]  J. D. Reid,et al.  Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin. , 1998, The Biochemical journal.

[11]  Ick Chan Kwon,et al.  Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[13]  S. Nishimura,et al.  Feasibility of polysaccharide hybrid materials for scaffolds in cartilage tissue engineering: evaluation of chondrocyte adhesion to polyion complex fibers prepared from alginate and chitosan. , 2004, Biomacromolecules.

[14]  Yasuo Suzuki,et al.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. , 2003, Journal of biomedical materials research. Part A.

[15]  Y. Inoue,et al.  Enzymatic hydrolysis of bacterial poly(3-hydroxybutyrate-co-3-hydroxypropionate)s by poly(3-hydroxyalkanoate) depolymerase from Acidovorax Sp. TP4. , 2002, Biomacromolecules.

[16]  Hwal Suh,et al.  Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. , 2003, Biomaterials.

[17]  A. Mikos,et al.  TGF-&bgr;1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function , 2001, The Journal of bone and joint surgery. American volume.

[18]  Masanori Yamada,et al.  Preparing Chitosan-Poly(acrylic Acid) Composite Fibers by Self-Assembly at an Aqueous Solution Interface , 2002 .

[19]  J L Cleland,et al.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.

[20]  K. Ohkawa,et al.  Adsorption of endocrine disruptors and related compounds using natural polymer composite fibers formed by polyion complexes , 2001 .

[21]  R F Valentini,et al.  Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. , 1997, Biomaterials.

[22]  J. Oh,et al.  Polyelectroylte complex composed of chitosan and sodium alginate for wound dressing application. , 1999, Journal of biomaterials science. Polymer edition.

[23]  K. De Yao,et al.  Controlled release of albumin from chitosan-alginate microcapsules. , 1994, Journal of pharmaceutical sciences.

[24]  Lonnie D Shea,et al.  Drug-releasing scaffolds fabricated from drug-loaded microspheres. , 2002, Journal of biomedical materials research.

[25]  K E Healy,et al.  A biodegradable polymer scaffold for delivery of osteotropic factors. , 2000, Biomaterials.

[26]  A. Wan,et al.  Encapsulation of biologics in self-assembled fibers as biostructural units for tissue engineering. , 2004, Journal of biomedical materials research. Part A.

[27]  Hanry Yu,et al.  Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. , 2002, Biomaterials.